Biotech News

MILPITAS, Calif. - -- Glycogen phosphorylase (EC 2.4.1.1) catalyzes the rate-limiting step in glycogenolysis using glycogen and inorganic phosphate to produce glucose-1-phosphate (G1P). In mammals, glycogen phosphorylase is abundant in muscle, liver...

GREEN BAY, Wis. - -- Badger Sheet Metal Works produces custom-designed industrial dryers

MILPITAS, Calif. - -- Glutamate dehydrogenase (GDH) (1.4.1.2) is a hexameric enzyme that catalyzes the reversible conversion of glutamate to α-ketoglutarate and ammonia while reducing NAD+ to NADH. Glutamate can be converted to α-ketoglutarate by GDH...

MILPITAS, Calif. - -- Myristoylation is a co- and post-translational modification of proteins. Myristoylated proteins are involved in cellular trafficking, cellular transformation and oncogenesis. In this modification, Myristic acid, a saturated fatty...

MILPITAS, Calif. - -- BioVision's OrgFrontierTM viable/non-viable cell separation kit is designed to separate the viable (live) cells from non-viable (dead) cells in cultured cell preparations. This kit can be used to remove dead or damaged cells that...

MILPITAS, Calif. - -- Adenosine Monophosphate (AMP), also known as 5'-adenylic acid, consists of adenine, ribose and phosphate. AMP can be produced during ATP synthesis by the enzyme adenylate kinase by combining two ADP molecules, as a result of the...

MILPITAS, Calif. - -- Lipid peroxidation is a type of oxidative damage that affects cellular membranes, lipoproteins, and other lipid-containing molecules. This series of chain reactions occur between highly reactive oxygen species and unsaturated fatty..

MILPITAS, Calif. - -- Lysosomal glucosylceramidase also  known  as acid  beta-glucosidase (E.C.3.2.1.45)  is a lysosomal  membrane  protein  that cleaves  the beta-glucosidic linkage of glycosylceramide (GC).The...

CovalX is proud to announce the latest innovative solution for High-Mass MALDI detection system. The OMEGATOF, a compact footprint with high-end technology to achieve maximum performance up to 1500 KDa.

SAN DIEGO - -- Mapp Biopharmaceutical, Inc. (MappBio), announced today that it has been awarded an advanced research and development contract for $16.5 million with options for an additional $30.0 million by the Biomedical Advanced Research and...

For monitoring 3' exonuclease activity in a wide variety of samples